Synlogic, Inc. (SYBX)
OTCMKTS · Delayed Price · Currency is USD
0.7010
-0.0067 (-0.95%)
At close: Mar 24, 2026
Synlogic Market Cap
Synlogic has a market cap or net worth of $8.2 million as of March 26, 2026. Its market cap has decreased by -46.48% in one year.
Market Cap
8.20M
Enterprise Value
-6.47M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.70
Market Cap Chart
Since August 28, 2017, Synlogic's market cap has decreased from 196.53M to 8.20M, a decrease of -95.83%. That is a compound annual growth rate of -30.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 8.20M | -37.41% |
| Dec 31, 2025 | 13.10M | -19.98% |
| Dec 31, 2024 | 16.37M | -53.72% |
| Dec 29, 2023 | 35.38M | -33.99% |
| Dec 30, 2022 | 53.60M | -68.23% |
| Dec 31, 2021 | 168.70M | 124.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibitor Therapeutics | 12.89M |
| Finch Therapeutics Group | 11.72M |
| Nymox Pharmaceutical | 11.43M |
| Brainstorm Cell Therapeutics | 9.57M |
| BetterLife Pharma | 9.51M |
| TRON Group | 8.18M |
| AccuStem Sciences | 7.71M |
| Bioxytran | 5.70M |